{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T21:02:30Z","timestamp":1786741350788,"version":"build-2736575974"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T00:00:00Z","timestamp":1647388800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004166","name":"Medical University of Warsaw","doi-asserted-by":"publisher","award":["No 1W51\/NM1\/15"],"award-info":[{"award-number":["No 1W51\/NM1\/15"]}],"id":[{"id":"10.13039\/501100004166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Immunocompromised women are at an increased risk of developing malignancies, especially those that are viral-induced, such as invasive cervical cancer caused by the human papillomavirus (HPV). The aim of the study was to describe gynecological follow-up of women undergoing chronic immunosuppressive therapy for various reasons (e.g., kidney\/liver transplant, systemic lupus erythematosus), diagnosed with a high-risk HPV (hrHPV) infection based on a self-sampling test. Twenty-six hrHPV-positive women were invited to take part in a gynecological follow-up, including a visual assessment of the anogenital region, two-handed gynecological examination, and cervical cytology as well as a colposcopy and cervical biopsy when necessary. Four women declined taking part in the study. Over six years of observation, low-grade squamous intraepithelial lesions (LSIL) were detected at least once in 7\/22 women (31.8%), and a cervical intraepithelial lesion 1 (CIN 1) histopathologic result was obtained five times in 3\/22 women. No cases of high-grade squamous intraepithelial lesions, CIN 2\/3, or invasive cervical cancers were observed. Loop electrosurgical excision procedure (LEEP) was performed in three patients. As immunocompromised women are prone to persistent hrHPV infections, they should be under strict gynecological supervision because only vigilant surveillance enables fast detection and treatment of early dysplasia and, therefore, provides a chance for the reduction of the cervical cancer burden.<\/jats:p>","DOI":"10.3390\/ijerph19063531","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T22:09:58Z","timestamp":1647468598000},"page":"3531","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A Six-Year Gynecological Follow-Up of Immunosuppressed Women with a High-Risk Human Papillomavirus Infection"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8504-654X","authenticated-orcid":false,"given":"Aleksandra","family":"Wielgos","sequence":"first","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9192-3323","authenticated-orcid":false,"given":"Bronis\u0142awa","family":"Pietrzak","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-115 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Suchonska","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-115 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6162-9916","authenticated-orcid":false,"given":"Mariusz","family":"Sikora","sequence":"additional","affiliation":[{"name":"National Institute of Geriatrics, Rheumatology and Rehabilitation, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8308-1023","authenticated-orcid":false,"given":"Lidia","family":"Rudnicka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2581-3668","authenticated-orcid":false,"given":"Miroslaw","family":"Wielgos","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Medical University of Warsaw, 02-115 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after Transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.critrevonc.2012.02.008","article-title":"HPV-Related (Pre)Malignancies of the Female Anogenital Tract in Renal Transplant Recipients","volume":"84","author":"Hinten","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.transproceed.2009.03.015","article-title":"Surveillance of Human Papilloma Virus Infection and Cervical Cancer in Kidney Transplant Recipients: Preliminary Data","volume":"41","author":"Veroux","year":"2009","journal-title":"Transpl. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcv.2011.05.017","article-title":"Cervical Human Papillomavirus in Transplanted Italian Women: A Long-Term Prospective Follow-up Study","volume":"51","author":"Origoni","year":"2011","journal-title":"J. Clin. Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fpubh.2017.00178","article-title":"Persistent Low-Risk and High-Risk Human Papillomavirus Infections of the Uterine Cervix in HIV-Negative and HIV-Positive Women","volume":"5","author":"Adebamowo","year":"2017","journal-title":"Front. Public Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/ajt.14181","article-title":"Reactivation of Latent HPV Infections After Renal Transplantation","volume":"17","author":"Hinten","year":"2017","journal-title":"Am. J. Transpl."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/9231031","article-title":"Importance of High-Risk Human Papillomavirus Infection Detection in Female Renal Transplant Recipients in the First Year after Transplantation","volume":"2018","author":"Cistjakovs","year":"2018","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1743-422X-9-117","article-title":"Prevalence of High-Risk Human Papillomavirus Cervical Infection in Female Kidney Graft Recipients: An Observational Study","volume":"9","author":"Pietrzak","year":"2012","journal-title":"Virol. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.transproceed.2008.05.074","article-title":"Human Papilloma Virus Infection and Cervical Intraepithelial Neoplasia in Transplanted Patients","volume":"40","author":"Paternoster","year":"2008","journal-title":"Transplant. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/ajt.13053","article-title":"Cervicovaginal HPV Infection in Female Renal Transplant Recipients: An Observational, Self-Sampling Based, Cohort Study: HPV in Female Renal Transplant Recipients","volume":"15","author":"Meeuwis","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/aogs.13261","article-title":"Cervical HPV Prevalence and Genotype Distribution in Immunosuppressed Danish Women","volume":"97","author":"Roensbo","year":"2018","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s10147-015-0940-2","article-title":"Clinical Outcomes of Abnormal Cervical Cytology and Human Papillomavirus-Related Lesions in Patients with Organ Transplantation: 11-Year Experience at a Single Institution","volume":"21","author":"Tanaka","year":"2016","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/aogs.12663","article-title":"Prevalence of Genital Dysplasia after Kidney Transplantation-a Retrospective, Non-Interventional Study from Two Centers","volume":"94","author":"Marschalek","year":"2015","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","article-title":"HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer","volume":"32","author":"Liu","year":"2018","journal-title":"AIDS"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"EBPG Expert Group on Renal Transplantation (2002). European Best Practice Guidelines for Renal Transplantation. Section IV: Long-Term Management of the Transplant Recipient. IV.6.3. Cancer Risk after Renal Transplantation. Solid Organ Cancers: Prevention and Treatment. Nephrol. Dial. Transpl., 17, 32\u201336.","DOI":"10.1093\/ndt\/17.suppl_4.32"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","article-title":"Performance of Human Papillomavirus Testing on Self-Collected versus Clinician-Collected Samples for the Detection of Cervical Intraepithelial Neoplasia of Grade 2 or Worse: A Randomised, Paired Screen-Positive, Non-Inferiority Trial","volume":"20","author":"Polman","year":"2019","journal-title":"Lancet Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Hawkes, D., Keung, M., Huang, Y., McDermott, T.L., Romano, J., Saville, M., and Brotherton, J. (2020). Self-Collection for Cervical Screening Programs: From Research to Reality. Cancers, 12.","DOI":"10.3390\/cancers12041053"},{"key":"ref_18","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2012). Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr. Eval. Carcinog. Risks Hum., 100 Pt B, 1\u2013441."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Wielgos, A., Pietrzak, B., Sikora, M., Martirosian, G., Suchonska, B., Gozdowska, J., Oldakowska-Jedynak, U., Jabiry-Zieniewicz, Z., Durlik, M., and Rudnicka, L. (2020). Human Papillomavirus (HPV) DNA Detection Using Self-Sampling Devices in Women Undergoing Long Term Immunosuppressive Therapy. Viruses, 12.","DOI":"10.3390\/v12090962"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/LGT.0000000000000414","article-title":"Cervical Cytology and Histology After Solid Organ Transplant: A Longitudinal Cohort Study","volume":"22","author":"Long","year":"2018","journal-title":"J. Low Genit. Tract. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00404-020-05621-3","article-title":"Cervical Cancer Screening Abnormalities in Immunosuppressed Renal Transplant Women: Case\u2013Control Study in Southern Brazil","volume":"302","author":"Klitzke","year":"2020","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13622","DOI":"10.1111\/tid.13622","article-title":"Incidence of Cervical Intraepithelial Lesions and Human Papilloma Virus Infection in Female Renal Transplant Recipients","volume":"23","author":"Cravioto","year":"2021","journal-title":"Transpl. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2011.1592","article-title":"Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients","volume":"306","author":"Engels","year":"2011","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1432-2277.2009.00975.x","article-title":"Skin Cancer and (Pre)Malignancies of the Female Genital Tract in Renal Transplant Recipients","volume":"23","author":"Meeuwis","year":"2010","journal-title":"Transpl. Int."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1002\/ijc.32565","article-title":"Human Papillomavirus-related Anogenital Premalignancies and Cancer in Renal Transplant Recipients: A Danish Nationwide, Registry-based Cohort Study","volume":"146","author":"Reinholdt","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study","volume":"11","author":"Quint","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/ijc.33035","article-title":"Cumulative risk of cervical intraepithelial neoplasia for women with normal cytology but positive for human papillomavirus: Systematic review and meta-analysis","volume":"147","author":"Volesky","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_28","unstructured":"(2022, January 08). Polish National Health Fund Website, Available online: https:\/\/www.nfz.gov.pl\/download\/gfx\/nfz\/pl\/defaultstronaopisowa\/483\/83\/1\/cytologia-objecie_populacji_1.01.2022r.xlsx."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"k4823","DOI":"10.1136\/bmj.k4823","article-title":"Detecting Cervical Precancer and Reaching Underscreened Women by Using HPV Testing on Self Samples: Updated Meta-Analyses","volume":"363","author":"Arbyn","year":"2018","journal-title":"BMJ"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Arbyn, M., Castle, P.E., Schiffman, M., Wentzensen, N., Heckman-Stoddard, B., and Sahasrabuddhe, V.V. (2022). Meta-analysis of agreement\/concordance statistics in studies comparing self- vs clinician-collected samples for HPV testing in cervical cancer screening. Int. J. Cancer, advance online publication.","DOI":"10.1002\/ijc.33967"},{"key":"ref_31","unstructured":"WHO (2021). WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, World Health Organization. [2nd ed.]. WHO Guidelines Approved by the Guidelines Review Committee."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5603\/GP.2021.0043","article-title":"Cervical Cancer Screening in Poland in Current SARS-CoV-2 Pandemic: Interim Guidelines of the Polish Society of Gynecologists and Obstetricians and the Polish Society of Colposcopy and Cervical Pathophysiology-a Summary January 2021","volume":"92","author":"Jach","year":"2021","journal-title":"Ginekol. Pol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"CA Cancer J. Clin."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/6\/3531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:37:41Z","timestamp":1760135861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/6\/3531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijerph19063531"],"URL":"https:\/\/doi.org\/10.3390\/ijerph19063531","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}